日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

更正:利用 PRMT5 作为靶点治疗以 ATM 和 TP53 频繁突变为特征的套细胞淋巴瘤的联合疗法

Che, Yuxuan; Liu, Yang; Yao, Yixin; Hill, Holly A; Li, Yijing; Cai, Qingsong; Yan, Fangfang; Jain, Preetesh; Wang, Wei; Rui, Lixin; Wang, Michael

YY1-Mediated Polycomb Group Function Safeguards Hematopoietic Stem Cells from Premature Aging

YY1介导的多梳蛋白功能保护造血干细胞免受过早衰老的影响

Saka, Sahitya; Lee, Junki P; Wang, Yinghua; Liu, Peng; Liu, Yunxia; Hong, Courtney; Kuehnl, Ashley; Rui, Lixin; Atchison, Michael L; Pan, Xuan

The pyruvate branch point controls lymphoid cancer cell dissemination

丙酮酸分支点控制淋巴癌细胞扩散

Khan, Hamidullah; John, Steven; Roy, Sushmita; Farhan, Mohd; Hoang, Nguyet Minh; Buethe, Patrick; Prasad, Aman; Nihal, Aman; Yang, David T; Rui, Lixin; Fan, Jing; Schieke, Stefan M

ASIC1a Induces Excessive Mitophagy and PANoptosis of Chondrocyte by the Inhibition of SIRT3 Mitochondrial Translocation.

ASIC1a 通过抑制 SIRT3 线粒体转位诱导软骨细胞过度自噬和泛凋亡。

Zai Zhuoyan, Qian Xuewen, Xu Yayun, Lv Huifang, Hao Mengjia, Tao Yueming, Rui Lixin, Zhang Xiaoyue, Peng Xiaoqing, Zhang Yihao, Chen Feihu

Analysis of Regulatory Botanical Submission Profile for Cancer Management from the U.S. FDA Perspectives

从美国FDA的角度分析用于癌症治疗的植物药监管申报概况

Park, Jin-Young K; Lee, Daniel; Rui, Lixin; Gao, Xiaoyue; Furness, M Scott; Wu, Charles

Development and Preclinical Evaluation of [(64)Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics

[(64)Cu]Cu-NOTA-ABDB6 的开发和临床前评价:一种具有改进药代动力学的 CD70 和白蛋白双重结合示踪剂

Li, Xiaoyan; Zhang, You; Mixdorf, Jason C; Wu, Qianyun; Lee, Sophia J; Engle, Jonathan W; Barnhart, Todd E; Kenney, Shannon C; Rui, Lixin; Wei, Weijun; Cai, Weibo

Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expression

fedratinib 与 venetoclax 联合用药对高 FLT3 表达的人类 B 细胞急性淋巴细胞白血病 (B-ALL) 具有活性

Rinella, Sean P; Bell, Haley C; Hess, Nicholas J; Hoang, Nguyet-Minh; Nguyen, Thao Trang; Turicek, David P; Shi, Lei; Rui, Lixin; LaBelle, James L; Capitini, Christian M

Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

利用PRMT5作为靶点进行联合治疗,治疗以ATM和TP53频繁突变为特征的套细胞淋巴瘤

Che, Yuxuan; Liu, Yang; Yao, Yixin; Hill, Holly A; Li, Yijing; Cai, Qingsong; Yan, Fangfang; Jain, Preetesh; Wang, Wei; Rui, Lixin; Wang, Michael

DNA methyltransferases in hematological malignancies

血液系统恶性肿瘤中的DNA甲基转移酶

Hoang, Nguyet-Minh; Rui, Lixin

Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors

抑制STAT3靶点SGK1可使弥漫性大B细胞淋巴瘤细胞对AKT抑制剂敏感。

Lu, Li; Zhu, Fen; Li, Yangguang; Kimpara, Shuichi; Hoang, Nguyet Minh; Pourdashti, Sheida; Rui, Lixin